Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Opinion in Biomedical Engineering is Scopus-indexed (Q1, CiteScore 8.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2468-4511Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$3,830 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 47 / 466 | 90th | Q1 |
| Biomedical Engineering | 74 / 342 | 78th | Q1 |
| Bioengineering | 43 / 168 | 74th | Q2 |
| Biomaterials | 40 / 146 | 72nd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q1, CiteScore 8.9.
Current Opinion in Biomedical Engineering is Q1 in Medicine (miscellaneous) (rank 47 of 466), Q1 in Biomedical Engineering (rank 74 of 342) and Q2 in Bioengineering (rank 43 of 168), by CiteScore 2025. It is ranked in 4 subject areas in all.
Current Opinion in Biomedical Engineering is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.9, which places it in quartile Q1 at the 90th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.848, quartile Q2, with an H-index of 54.
The publisher lists an article processing charge of about US$3,830 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Current Opinion in Biomedical Engineering is published by Elsevier B.V. Its ISSN is 2468-4511.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Opinion in Biomedical Engineering has an h-index of 61 and a 2-year mean of 3.75 citations per paper (OpenAlex). Its Scopus CiteScore is 8.9, quartile Q1. On 2-year citations it ranks #78 of 451 Scopus journals in Medicine (miscellaneous).
Current Opinion in Biomedical Engineering published 70 papers in 2025; its busiest recent year was 2021 with 102. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from United States (51.4%), United Kingdom (6.4%) and Netherlands (4.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (1.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.